Other News To Note

June 2013
BioWorld Today;6/14/2013, Vol. 24 Issue 114, p2
The article offers biopharma news briefs. A laboratory services agreement was signed by biotech company Amarantus Bioscience Holdings Inc. with medical technology company Becton, Dickinson and Co. (BD) Biosciences. The approved use of Xgeva (denosumab) from biotech company Amgen Inc. has been expanded by the Food and Drug Administration (FDA). A Paragraph IV notice letter from pharmaceutical company Exela Pharma Sciences LLC was received by pharmaceutical company Cornerstone Therapeutics Inc.


Related Articles

  • Other News To Note.  // BioWorld Today;8/13/2013, Vol. 24 Issue 154, p2 

    This section offers news briefs related to biopharmaceutical firms in the U.S. as of August 2013. A stock agreement was signed between Aastrom Biosciences Inc. and finance company Eastern Capital Ltd. Advanced Cell Technology Inc. proposes a reverse split of shares to its stockholders. Amarantus...

  • Other News To Note.  // BioWorld Today;12/4/2013, Vol. 24 Issue 232, p2 

    The article provides news briefs regarding pharmaceutical industry. Amarantus Bioscience Holdings Inc. has signed an agreement with University of Miami to license the Bascom Palmer Eye Institute's method to use intellectual property surrounding the use of MANF and CDNF neurotrophins for the...

  • Other News To Note.  // BioWorld Today;6/24/2013, Vol. 24 Issue 120, p5 

    The article offers news brief as of June 21, 2013 related to pharmaceutical industry. Amarantus Bioscience Holdings Inc. announces plan for evaluating its Lympro test used for diagnosing chronic traumatic encephalopathy (CTE). Bellus Health Inc. has agreed to acquire Thallion Pharmaceuticals...

  • Appointments and Advancements.  // BioWorld Today;9/23/2013, Vol. 24 Issue 182, p10 

    The article announces the appointments in the pharmaceutical industry as of September 2013, including Kaushik J. Dave as president and chief executive officer (CEO) of Actinium Pharmaceuticals Inc., Mark Leuchtenberger as president and CEO of Acusphere Inc., and F. Randall Grimes as director of...

  • BD Rx Business Acquired By Fresenius Kabi USA.  // Chain Drug Review;2/22/2016, Vol. 38 Issue 4, p54 

    The article reports that health care company Frenesius Kabi USA has acquired the pharmacy business of Becton Dickinson & Co. including a pharmaceutical manufacturing plan and the BD Simplist line of drugs in ready-to-administer prefilled glass syringes.

  • INDUSTRY PIPELINE.  // Pharmaceutical Technology;Apr2006, Vol. 30 Issue 4, p106 

    The article reports on developments in the pharmaceutical industry. BD Medical has developed its "BD TSCF" packaging for the secure transfer of sterile prefillable syringe components into the pharmaceutical filling environment. Precision Pharma Services offers a brochure describing its...

  • Becton Dickinson is on the cutting edge. Doyle, B.G. // Caribbean Business;8/21/2003, Vol. 31 Issue 33, pS8 

    Reports on Becton Dickinson & Co.'s expansion with a number of high-tech production facilities throughout Puerto Rico. Use of automated equipment in manufacturing special safety scalpels and blades; Result of U.S. legislation that requires all sharp instruments to have a safety guard;...

  • Community Champion. Upton, Julian // Pharmaceutical Executive;Jul2015, Vol. 35 Issue 7, p26 

    The article offers the author's insights on global president Ken Miller for BD Diabetes Care (BD), a medical technology company. Topics discussed include his educational and career background, the Leadership Standard focuses on improving the development of key talent at various levels, and his...

  • Wyeth and BD Medical Collaborate on Vaccine.  // Pharmaceutical Technology;Sep2006, Vol. 30 Issue 9, p130 

    The article focuses on the collaboration of Wyeth Pharmaceuticals company and BD Medical company in delivering an infant meningitis vaccine in New Jersey. Wyeth launched its Prevnar vaccine using BD Medical's Hypak SCF vaccine-delivery technology. The single-use Hypak system eliminates the need...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics